Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants

Journal of Infectious Diseases

Volumn 211, Issue 3, 2015, Pages 338-346

  Tchakoute, Christophe Toukam ^a   Hesseling, Anneke C ^c   Kidzeru, Elvis B ^a   Gamieldien, Hoyam ^a,b   Passmore, Jo Ann S ^b,d   Jones, Christine E ^b,e   Gray, Clive M ^a,d   Sodora, Donald L ^f   Jaspan, Heather B ^a,f  

^a Institute of Infectious Disease and Molecular Medicine   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^e UNIVERSITY OF LONDON   (United Kingdom)

^f SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

BCG vaccination; infants; intracellular cytokines; maternal HIV; T cell proliferation

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

AGE; ARTICLE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RESPONSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGENICITY; INFANT; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRENATAL EXPOSURE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TUBERCULOSIS; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; PROCEDURES; VACCINATION;

BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV; HIV INFECTIONS; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MALE; TUBERCULOSIS; VACCINATION;

EID: 84922572868     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu434     Document Type: Article

References (29)

1. World Health Organization. Global tuberculosis report 2013. Geneva, Switzerland: WHO, 2013:6-8.
2. Marchant A, Goetghebuer T, Ota MO, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol 1999; 163:2249-55.
3. Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367: 1173-80.
4. Hesseling AC, Rabie H, Marais BJ, et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 2006; 42:548-58.
5. Rabie H, Violari A, Duong T, et al. Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis. Int J Tuberc Lung Dis 2011; 15:1194-200.
6. World Health Organisation. BCG vaccine WHO position paper. Wkly Epidemiol Rec 2004; 79:27-40.
7. Meeting of the immunization Strategic Advisory Group of Experts, April 2007-conclusions and recommendations. Wkly Epidemiol Rec 2007; 181-93.
8. Hesseling AC, Caldwell J, Cotton MF, et al. BCG vaccination in South African HIV-exposed infants-risks and benefits. S Afr Med J 2009; 99:88-91.
9. Van Rie A, Madhi SA, Heera JR, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol 2006; 13:246-52.
10. Mazzola TN, Da Silva MT, Abramczuk BM, et al. Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfect-ed infants. AIDS 2011; 25:32834.
11. Kagina BMN, Abel B, Bowmaker M, et al. Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response. Vaccine 2009; 27:5488-95.
12. Burl S, Adetifa UJ, Cox M, et al. Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol 2010; 185:2620-8.
13. World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. 64th WMA General Assembly, Fortaleza, Brazil, October 2013. Bull World Health Organ 2001; 79:373-4.
14. City of Cape Town Department of Health. City Health HIV, AIDS, STI and TB plan 2012/2013. Cape Town, South Africa: City of Cape Town, 2011.
15. The National Department of Health, Republic of South Africa. Expanded program on immunisation. Pretoria, 2009.
16. Soares A, Govender L, Hughes J, et al. Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J Immunol Methods 2010; 362:43-50.
17. Rueggs CL, Rajasekar S, Stein S, Engleman EG. Degradation of CD4 following Phorbol-induced Internalization in Human T Lymphocytes. J Biol Chem 1992; 267:18837-49.
18. Kideru EB, Hesseling AC, Passmore JA, et al. In-utero exposure to mat-iernal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS 2014; 28:1421-30.
19. Rich KC, Siegel JN, Jennings C, Rydman RJ. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol 1997; 4:358-61.
20. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
21. Reed SG, Coler RN, Tand E, et al. Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proc Natl Acad Sci USA 2009; 106:2301-6.
22. Beveridge NER, Price DA, Casazza JP, et al. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Myco-bacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol 2007; 37:3089-100.
23. Mueller H, Detjen AK, Schuck SD, et al. Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine 2008; 43:2008.
24. Velilla P, Rugeles MT. Defective antigen-presenting cell function in human neonates. Clin Immunol 2007; 121:251-9.
25. Marodi L. Down-regulation of Th1 responses in human neonates. Clin Exp Immunol 2002; 128:1-2.
26. Rose S, Lichtenheld M, Foote MR, Adkins B. Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. J Immunol 2007; 178:2667-78.
27. Soares AP, Kwong Chung CKC, Choice T, et al. Longitudinal changes in CD4+ T-cell memory responses induced by BCG vaccination of new-borns. J Infect Dis 2013; 207:1084-94.
28. Cotton MF, Schaaf HS, Lottering G, et al. Tuberculosis exposure in HIV-exposed infants in a high prevalence setting. Int J Tuberc Lung Dis 2008; 12:225-7.
29. Madhi SA, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011; 365:21-31.